title: Signal transduction pathways that inhibit hepatitis B virus replication.
abstract: The replication of hepatitis B virus (HBV) in hepatocytes is strongly inhibited in response to IFN-alpha/beta and IFN-gamma. Although it has been previously demonstrated that IFN-alpha/beta eliminates HBV RNA-containing capsids from the cell in a proteasome-dependent manner, the precise cellular pathway that mediates this antiviral effect has not been identified. Because IFN-induced signal transduction involves kinase-mediated activation of gene expression, we used an immortalized hepatocyte cell line that replicates HBV in an IFN-sensitive manner to investigate the role of cellular kinase activity and the cellular transcription and translation machinery in the antiviral effect. Our results indicate that Janus kinase activity is required for the antiviral effect of IFN against HBV, but that phosphatidylinositol 3-kinase, cyclin-dependent kinase, mitogen-activated protein kinase, and NF-kappaB activity are not. Additionally, we found that inhibitors of cellular transcription and translation completely abolish the antiviral effect, which also appears to require cellular kinase activity downstream of signal transduction and gene expression. Collectively, these results identify IFN-regulated pathways that interrupt the HBV replication cycle by eliminating viral RNA-containing capsids from the cell, and they provide direction for discovery of the terminal effector molecules that ultimately mediate this antiviral effect.
authors.affiliation: Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Robek
authors.forename: Bryan S
authors.initials: BS
authors.lastname: Boyd
authors.forename: Stefan F
authors.initials: SF
authors.lastname: Wieland
authors.forename: Francis V
authors.initials: FV
authors.lastname: Chisari
mesh_terms: D000818:Animals; D002461:Cell Line, Transformed; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006515:Hepatitis B virus / Q000502:physiology*; D007372:Interferons / Q000037:antagonists & inhibitors / Q000494:pharmacology; D051379:Mice; D014176:Protein Biosynthesis / Q000187:drug effects; D015398:Signal Transduction; D014158:Transcription, Genetic / Q000187:drug effects; D014779:Virus Replication
chemical_list: D004791:Enzyme Inhibitors; D007372:Interferons